Autoimmunity in coxsackievirus infection

Current Topics in Microbiology and Immunology

Volumn 323, Issue , 2008, Pages 293-314

  Rose, N R ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; ANTIBODY; MYOSIN; MYOSIN ANTIBODY; NITRIC OXIDE; AUTOANTIBODY; CARDIAC MYOSIN; COMPLEMENT;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; COMPLEMENT SYSTEM; COXSACKIE VIRUS B3; COXSACKIE VIRUS INFECTION; DISEASE PREDISPOSITION; GENETIC REGULATION; HUMAN; IMMUNOPATHOLOGY; INNATE IMMUNITY; MACROPHAGE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TH1 CELL; TH2 CELL; VIRUS MYOCARDITIS; ANIMAL; HELPER CELL; IMMUNOLOGY; METABOLISM; MYOCARDITIS; PHYSIOLOGY; VIROLOGY;

COXSACKIEVIRUS; MURINAE; MUS;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CARDIAC MYOSINS; COMPLEMENT SYSTEM PROTEINS; COXSACKIEVIRUS INFECTIONS; HUMANS; MYOCARDITIS; NITRIC OXIDE; T-LYMPHOCYTES; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 43649097603     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-540-75546-3_14     Document Type: Review

References (89)

1. Afanasyeva M, Rose NR (2004) Viral infection and heart disease: autoimmune mechanisms. In: Schoenfeld Y, Rose NR (eds) Infection and autoimmunity. Elsevier, Amsterdam, pp 299-318
2. Afanasyeva M, Wang Y, Kaya Z, Park S, Zilliox MJ, Schofield BH, Hill SL, Rose NR (2001a) Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype. Am J Pathol 159:193-203
3. Afanasyeva M, Wang Y, Kaya Z, Stafford EA, Dohmen KM, Sadighi Akha AA, Rose NR (2001b) Interleukin-12 recepter/STAT4 signaling is required for the development of autoimmune myocarditis in mice by an interferon-γ- independent pathway. Circulation 104:3145-3151
4. Afanasyeva M, Georgakopoulos D, Belardi DF, Ramsundar AC, Barin JG, Kass DA, Rose NR (2004a) Quantitative analysis of myocardial inflammation by flow cytometry in murine autoimmune myocarditis. Am J Pathol 164:807-815
5. Afanasyeva M, Georgakopoulos D, Rose NR (2004b) Autoimmune myocarditis: cellular mediators of cardiac dysfunction. Autoimmun Rev 3:476-486
6. Afanasyeva M, Georgakopoulos D, Belardi DF, Bedja D, Fairweather D, Wang Y, Kaya Z, Gabrielson KL, Rodriguez ER, Caturegli P, Kass DA and Rose NR (2005) Impaired upregulation of CD25 on CD4+ T cells in IFN-γ knockout mice is associated with progression of myocarditis to heart failure. Proc Natl Acad Sci U S A 102:180-185
7. 3: identification of heart autoantigens. Clin Immunol Immunopathol 43:129-139
8. Barin JG, Talor MV, Sharma RB, Rose NR, Burek CL (2005) Iodination of murine thyroglobulin enhances autoimmune reactivity in the NODH2h4 mouse. Clin Exp Immunol 142:251-259
9. Caforio AL, Grazzini M, Mann JM, Keeling PJ, Bottazzo GF, McKenna WJ, Schiaffino S (1992) Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation 85:1734-1742
10. Caforio AL, Mahon NJ, McKenna WJ (2001) Cardiac autoantibodies to myosin and other heart-specific autoantigens in myocarditis and dilated cardiomyopathy. Autoimmunity 34:199-204
11. Caforio AL, Mahon NJ, Tona F, McKenna WJ (2002) Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance. Eur J Heart Fail 4:411-417
12. Camargo PR, Snitcowsky R, da Luz PL, Mazzieri R, Higuchi ML, Rati M, Stolf N, Ebaid M, Pileggi F (1995) Favorable effects of immunosuppressive therapy in children with dilated cardiomyopathy and active myocarditis. Pediatr Cardiol 16:61-68
13. Cihakova D, Jobert G. Barin, Marina Afanasyeva, Miho Kimura, DeLisa Fairweather, Michael Berg, Monica V Talor, G. Christian Baldeviano, Sylvia Frisancho, Kathleen Gabrielson, Djahida Bedja, Noel R. Rose (2008) IL 13 protects against experimental autoimmune myocarditis by regulating macrophage differentiation. Amer J Pathol Accepted.
14. Cunningham MW (2004) T cell mimicry in inflammatory heart disease. Mol Immunol 40:1121-1127
15. Dec GW Jr, Palacios IF, Fallon JT, Aretz HT, Mills J, Lee DC, Johnson RA (1985) Active myocarditis in the spectrum of acute dilated cardiomyopathies: clinical features, histologic correlates, and clinical outcome. N Engl J Med 312:885-890
16. Donermeyer DL, Beisel KW, Allen PM, Smith SC (1995) Myocarditis-inducing epitope of myosin binds constitutively and stably to I-Ak on antigen-presenting cells in the heart. J Exp Med 182:1291-1300
17. Dorffel WV, Wallukat G, Dorffel Y, Felix SB, Baumann G (2004) Immunoadsorption in idiopathic dilated cardiomyopathy, a 3-year follow-up. Int J Cardiol 97:529-534
18. Elliott JF, Liu J, Yuan ZN, Bautista-Lopez N, Wallbank SL, Suzuki K, Rayner D, Nation P, Robertson MA, Liu G, Kavanagh KM (2003) Autoimmune cardiomyopathy and heart block develop spontaneously in HLA-DQ8 transgenic IAbeta knockout NOD mice. Proc Natl Acad Sci U S A 100:13447-13452
19. Fairweather D, Kaya Z, Shellam GR, Lawson CM, Rose NR (2001) From infection to autoimmunity. J Autoimmun 16:175-186
20. Fairweather D, Yusung S, Frisancho S, Barrett M, Gatewood S, Steele R, Rose NR (2003) IL-12 receptor beta 1 and Toll-like receptor 4 increase IL-1 beta- and IL-18-associated myocarditis and coxsackievirus replication. J Immunol 170:4731-4737
21. Fairweather D, Afanasyeva M, Rose NR (2004a) Cellular immunity: a role for cytokines. In: Doria A, Pauletto P (eds) Handbook of systemic autoimmune diseases. Vol 1: The heart in systemic autoimmune diseases. Elsevier, Amsterdam, pp 3-17
22. Fairweather D, Frisancho-Kiss S, Gatewood S, Njoku D, Steele R, Barrett M, Rose NR (2004b) Mast cells and innate cytokines are associated with susceptibility to autoimmune heart disease following Coxsackievirus B3 infection. Autoimmunity 37:131-145
23. Fairweather D, Frisancho-Kiss S, Rose NR (2005) Viruses as adjuvants for autoimmunity: evidence from Coxsackievirus-induced myocarditis. Rev Med Virol 15:17-27
24. Fairweather D, Frisancho-Kiss S, Njoku DB, Nyland JF, Kaya Z, Yusung SA, Davis SE, Frisancho JA, Barrett MA, Rose NR (2006) Complement receptor 1 and 2 deficiency increases Coxsackievirus B3-induced myocarditis, dilated cardiomyopathy, and heart failure by increasing macrophages IL-1β, and immune complex deposition in the heart. J of Immunol 176:3516-3524
25. Feldman AM, McNamara D (2000) Myocarditis. N Engl J Med 343:1388-1398
26. Felix SB, Staudt A (2006) Non-specific immunoadsorption in patients with dilated cardiomyopathy: mechanisms and clinical effects. Int J Cardiol 112:30-33
27. Felix SB, Staudt A, Friedrich GB (2001) Improvement of cardiac function after immunoadsorption in patients with dilated cardiomyopathy. Autoimmunity 34:211-215
28. Freedman NJ, Lefkowitz RJ (2004) Anti-beta(1)-adrenergic receptor antibodies and heart failure: causation, not just correlation. J Clin Invest 113:1379-1382
29. Frisancho-Kiss S, Nyland JF, Davis SE, Barrett MA, Gatewood SJL, Njoku DB, Cihakova D, Silbergeld EK, Rose NR, Fairweather D (2006) Cutting edge: T cell Ig mucin-3 reduces inflammatory heart disease by increasing CTLA-4 during innate immunity. J Immunol 176:6411-6415
30. Frustaci A, Pieroni M, Chimenti C (2006) Immunosuppressive treatment of chronic non-viral myocarditis. Ernst Schering Res Found Workshop 55:343-351
31. Fu LX, Magnusson Y, Bergh CH, Liljeqvist JA, Waagstein F, Hjalmarson A, Hoebeke J (1993) Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy. J Clin Invest 91:1964-1968
32. Gagliardi MG (2006) Dilated cardiomyopathy in children. Acta Paediatr Suppl 95:14-16
33. Gagliardi MG, Bevilacqua M, Bassano C, Leonardi B, Boldrini R, Camassei FD, Fierabracci A, Ugazio AG, Bottazzo GF (2004) Long term follow up of children with myocarditis treated by immunosuppression and of children with dilated cardiomyopathy. Heart 90:1167-1171
34. H2: a procrustean paradigm. Nat Immunol 4:503-505
35. Goser S, Ottl R, Brodner A, Dengler TJ, Torzewski J, Egashira K, Rose NR, Katus HA , Kaya Z (2005) Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1α in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy. Circulation 112:3400-3407
36. Goser S, Andrassy M, Buss SJ, Leuschner F, Volz CH, Ottl R, Zittrich S, Blaudeck N, Hardt SE, Pfitzer G, Rose NR, Katus HA, Kaya Z (2006) Cardiac troponin I but not cardiac troponin T induces severe autoimmune inflammation in the myocardium. Circulation 114:1693-1702
37. Guler ML, Ligons D, Rose NR (2005a) Genetics of autoimmune myocarditis. In: Oksenberg J, Brassat D (eds) Immunogenetics of autoimmune disease. Landis Bioscience/ Springer, Berlin New York Heidelberg, pp 144-151
38. Guler ML, Ligons DL, Wang Y, Bianco M, Broman KW, Rose NR (2005b) Two autoimmune diabetes loci influencing T cell apoptosis control susceptibility to experimental autoimmune myocarditis. J Immunol 174:2167-2173
39. Hayward SL, Bautista-Lopez N, Suzuki K, Atrazhev A, Dickie P, Elliott JF (2006) CD4 T cells play major effector role and CD8 T cells initiating role in spontaneous autoimmune myocarditis of HLA-DQ8 transgenic IAb knockout nonobese diabetic mice. J Immunol 176:7715-7725
40. 3 murine myocarditis: wide pathologic spectrum in genetically defined inbred strains. Hum Pathol 16:671-673
41. Hill SL, Rose NR (2001) The transition from viral to autoimmune myocarditis. Autoimmunity 34:169-176
42. nd edn. Taylor and Francis, New York, pp 951-964
43. Jane-wit D, Tuohy VK (2006) Autoimmune cardiac-specific T cell responses in dilated cardiomyopathy. Int J Cardiol 112:2-6
44. Kaya Z, Rose NR (2005) Innate immunity in experimental autoimmune myocarditis. In: Zouali M (ed) Molecular autoimmunity. Springer Science/Business Media, New York, pp 1-12
45. Kaya Z, Afanasyeva M, Wang Y, Dohmen KM, Schlichting J, Tretter T, Fairweather D, Holers VM, Rose NR (2001) Contribution of the innate immune system to autoimmune myocarditis: a role for complement. Nat Immunol 2:739-745
46. Kaya Z, Tretter T, Schlichting J, Leuschner F, Afanasyeva M, Katus HA, Rose NR (2005) Complement receptors regulate lipopolysaccharide-induced T-cell stimulation. Immunol 114:493-497
47. Lane JR, Neumann DA, Lafond-Walker A, Herskowitz A, Rose NR (1991) LPS promotes CB3-induced myocarditis in resistant B10.A mice. Cell Immunol 136:219-233
48. Lane JR, Neumann DA, Lafond-Walker A, Herskowitz A, Rose NR (1992) Interleukin 1 or tumor necrosis factor can promote Coxsackie B3-induced myocarditis in resistant B10.A mice. J Exp Med 175:1123-1129
49. Liao Li Sindhwani R, Rojkind M, Factor S, Leinwand L, Diamond B (1995) Antibody-mediated autoimmune myocarditis depends on genetically determined target organ sensitivity. J Exp Med 181:1123-1131
50. Limas CJ, Goldenberg IF, Limas C (1989) Autoantibodies against beta-adrenoceptors in human idiopathic dilated cardiomyopathy. Circ Res 64:97-103
51. Lowenstein CJ, Hill SL, Lafond-Walker A, Wu J, Allen G, Landavere M, Rose NR, Herskowitz A (1996) Nitric oxide inhibits viral replication in murine myocarditis. J Clin Invest 97: 1837-1843
52. Magnani JW, Dec GW (2006) Myocarditis: current trends in diagnosis and treatment. Circulation 113:876-890
53. Magnusson Y, Marullo S, Hoyer S, Waagstein F, Andersson B, Vahlne A, Guillet JG, Strosberg AD, Hjalmarson A, Hoebeke J (1990) Mapping of a functional autoimmune epitope on the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy. J Clin Invest 86:1658-1663
54. Mobini R, Maschke H, Waagstein F (2004) New insights into the pathogenesis of dilated cardiomyopathy: possible underlying autoimmune mechanisms and therapy. Autoimmun Rev 3:277-284
55. 3-induced myocarditis. J Immunol 138:2488-2492
56. Neu N, Rose NR, Beisel KW, Herskowitz A, Gurri-Glass G, Craig SW (1987b) Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol 139:3630-3636
57. Neumann DA, Burek CL, Baughman KL, Rose NL, Herskowitz A (1990) Circulating heart-reactive antibodies in patients with myocarditis or cardiomyopathy. J Am Coll. Cardiol 16:839-846
58. Neumann DA, Lane JR, Wulff SM, Allen GS, LaFond-Walker A, Herskowitz A, Rose NR (1992) In vivo deposition of myosin-specific autoantibodies in the hearts of mice with experimental autoimmune myocarditis. J Immunol 148:3806-3813
59. Neumann DA, Rose NR, Ansari AA, Herskowitz A (1994) Induction of multiple heart autoantibodies in mice with Coxsackievirus B3- and cardiac myosin-induced autoimmune myocarditis. Immunology 152:343-350
60. Nishii M, Inomata T, Niwano H, Takehana H, Takeuchi I, Nakano H, Shinagawa H, Naruke T, Koitabashi T, Nakahata J, Izumi T (2006) Beta2-Adrenergic agonists suppress rat autoimmune myocarditis: potential role of beta2-adrenergic stimulants as new therapeutic agents for myocarditis. Circulation 114:936-944
61. Oakley CM (2000) Spontaneous early clinical remission of myocarditis without immunosuppressive treatment. Ital Heart J 1:762-763
62. Penninger JM, Neu N, Timms E, Wallace VA, Koh D-R, Kishihara K, Pummerer C, Mak TW (1993) Induction of experimental autoimmune myocarditis in mice lacking CD3 or CD8 molecules. J Exp Med 178:1837-1842
63. Pummerer CL, Luze K, Grassi G, Bachmaier K, Offner F, Burrell SK, Lenz DM, Zamborelli TJ, Penninger JM, Neu NJ (1996) Identification of cardiac myosin peptides capable of inducing autoimmune myocarditis in BALB/c Mice. Clin Invest 97:2057-2062
64. Rangachari M, Mauermann N, Marty RR, Dirnhofer S, Kurrer MO, Komnenovic V, Penninger JM, Eriksson U (2006) T-beta negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17. J Exp Med 203:2009-2019
65. Rose NR (2005) The significance of autoimmunity in myocarditis. In: Schultheiss HP, Kapp JF, Grotzbach G (eds) Ernst Schering Res Found Workshop 55: Chronic viral and inflammatory cardiomyopathy. Springer, Berlin New York Heidelberg, pp 141-154
66. Rose NR (2006) Life amidst the contrivances. Nat Immunol 7:1009-1011
67. Rose NR, Afanasyeva M (2003) From infection to autoimmunity: the adjuvant effect. ASM News 69:132-137
68. Rose NR, Griffin DE (1991) Virus-induced autoimmunity. In: Talal N (ed) Molecular autoimmunity. Academic, San Diego, pp 247-272
69. Rose NR, Mackay IR (2000) Molecular mimicry: a critical look at exemplary instances in human diseases. Cell Mol Life Sci 57:542-551
70. 3-induced myocarditis. Ann N Y Acad Sci 475:146-156
71. Rose NR, Beisel KW, Herskowitz A, Neu N, Wolfgram LJ, Alvarez FL, Traystman MD, Craig SW (1987) Cardiac myosin and autoimmune myocarditis. In:Evered D, Whelan J (eds) Autoimmunity and autoimmune disease. Ciba Foundation Symposium 129. John Wile, Chichester UK, pp 3-24
72. Schimke I, Muller J, Dandel M, Gremmels H-D, Bayer W, Wallukat B, Wallukat G, Hetzer R (2005) Reduced oxidative stress in parallel to improved cardiac performance one year after selective removal of anti-beta 1-adrenoreceptor autoantibodies in patients with idiopathic dilated cardiomyopathy: data of a preliminary study. J Clin Apheresis 20:137-142
73. Smith SC, Allen PM (1991) Myosin-induced acute myocarditis is a T cell-mediated disease. J Immunol 147:2141-2147
74. Smith SC, Allen PJ (1993) The role of T cells in myosin-induced autoimmune myocarditis. 68:100-106
75. Sonderegger I, Rohn TA, Kurrer MO, Iezzi G, Zou Y, Kastelein RA, Bachmann MF, Kopf M (2006) Neutralization of IL-17 by active vaccination inhibits IL-23-dependent autoimmune myocarditis. Eur J Immunol 11:2849-2856
76. Staudt A, Bohm M, Knebel F, Grosse Y, Bischoff C, Hummel A, Dahm JB, Borges A, Jochmann N, Wernecke KD, Wallukat G, Baumann G, Felix SB (2002) Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy. Circulation 106:2448-2453
77. Staudt A, Dorr M, Staudt Y, Bohm M, Probst M, Empen K, Plotz S, Maschke HE, Hummel A, Baumann G, Felix SB (2005) Role of immunoglobulin G3 subclass in dilated cardiomyopathy: results from protein A immunoadsorption. Am Heart J 150:729-736
78. th edn. ASM Press, Washington DC, pp 1101-1109
79. Tam PE (2006) Coxsackievirus myocarditis: interplay between virus and host in the pathogenesis of heart disease. Viral Immunol 19:133-146
80. Wallukat G, Nissen E, Neichel D, Harris J (2002) Spontaneously beating neonatal rat heart myocyte culture-a model to characterize angiotensin II at(1) receptor autoantibodies in patients with preeclampsia. In Vitro Cell Dev Biol Anim 38:376-377
81. Wallukat G, Podlowski S, Nissen E, Morwinski R, Csonka C, Tosaki A, Blasig IE (2003) Functional and structural characterization of anti-beta1-adrenoceptor autoantibodies of spontaneously hypertensive rats. Mol Cell Biochem 251:67-75
82. Wallukat G, Englert A, Muller J, Dandel M, Lehmkuhl H, Wallukat B, Hetzer R (2006) Immunoadsorption - rationale and clinical results. Autoimmun Rev 5:225-226
83. Wang Y, Afanasyeva M, Hill SL, Rose NR (1999) Characterization of murine autoimmune myocarditis induced by self and foreign cardiac myosin. Autoimmunity 31:151-162
84. Warraich RS, Dunn MJ, Yacoub MH (1999) Subclass specificity of autoantibodies against myosin in patients with idiopathic dilated cardiomyopathy: pro-inflammatory antibodies in DCM patients. Biochem Biophys Res Commun 259:255-261
85. Warraich RS, Noutsias M, Kazak I, Seeberg B, Dunn MJ, Schultheiss HP, Yacoub MH, Kuhl U (2002) Immunoglobulin G3 cardiac myosin autoantibodies correlate with left ventricular dysfunction in patients with dilated cardiomyopathy: immunoglobulin G3 and clinical correlates. Am Heart J 143:1076-1084
86. Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, Glanowska G, Wilczewski P, Niklewski T, Zembala M, Polonski L, Rozek MM, Wodniecki J (2001) Randomized placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation 104:39-45
87. 3 myocarditis. J Exp Med 161:1112-1121
88. 3-induced myocarditis among different strains of mice. J Immunol 136:1846-1852
89. Wolfgram LJ, Rose NR (1989) Coxsackievirus infection as a trigger of cardiac autoimmunity. Immunol Res 8:61-80